Novel Oral Cannabinoid CBD Formulations Patent Application
Summary
USPTO published patent application US20260097052A1 for novel oral CBD formulations by five inventors including Hardin Matthew Jackson et al. The application covers solid oral dosage forms comprising the non-psychoactive cannabinoid CBD and methods of manufacture for treating diseases.
What changed
USPTO published patent application US20260097052A1 for novel oral CBD formulations on April 9, 2026. The application covers solid oral dosage forms comprising non-psychoactive cannabinoid CBD, methods of manufacture, and use for treating diseases. Inventors include Hardin Matthew Jackson, Devin Douglas Machin, Jinhee Oh, Venkat Reddy Goskonda, and Andrew Jonathan Saich. The application was filed December 12, 2025 under application number 19418328.\n\nAffected parties including pharmaceutical manufacturers, drug developers, and CBD product companies should monitor this application for potential licensing opportunities or freedom-to-operate concerns. The patent scope covering CBD solid oral dosage forms may impact competitive positioning in the pharmaceutical CBD space.
What to do next
- Monitor for patent grant status
- Review application for freedom-to-operate analysis
- Assess licensing opportunities for CBD formulations
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL ORAL CANNABINOID FORMULATIONS
Application US20260097052A1 Kind: A1 Apr 09, 2026
Inventors
Hardin Matthew Jackson, Devin Douglas Machin, Jinhee Oh, Venkat Reddy Goskonda, Andrew Jonathan Saich
Abstract
The present disclosure relates to novel pharmaceutical formulations, including solid oral dosage forms comprising the non-psychoactive cannabinoid cannabidiol (CBD). The disclosure further relates to methods of manufacture of the pharmaceutical formulations and the use of the formulations to treat diseases and conditions.
CPC Classifications
A61K 31/658 A61K 9/4858 A61K 9/4866
Filing Date
2025-12-12
Application No.
19418328
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.